220 related articles for article (PubMed ID: 28893806)
1. Low-dose intrapleural alteplase (without deoxyribonuclease) in complicated parapneumonic effusion: case series and literature reviews.
Lai C; Mohammad N; Hassan TM; Abdul Hamid MF
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28893806
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural alteplase in a patient with complicated pleural effusion.
Walker CA; Shirk MB; Tschampel MM; Visconti JA
Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
4. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
Muhammad Redzwan SRA
Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
[TBL] [Abstract][Full Text] [Related]
5. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
6. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
Wells RG; Havens PL
Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.
Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG
Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131
[TBL] [Abstract][Full Text] [Related]
9. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
11. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
12. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
13. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
Smith D; Shaw H; Ryder T
Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural Thrombolytics for Parapneumonic Effusion: A Network Metaanalysis.
Sridharan K; Sivaramakrishnan G
Curr Rev Clin Exp Pharmacol; 2024; 19(2):204-212. PubMed ID: 36173062
[TBL] [Abstract][Full Text] [Related]
16. Combined intrapleural alteplase and DNase therapy in complicated pleural infection arising from postsurgery oesophageal leak.
Ng BH; Nik Abeed NN; Ban AY; Abdul Hamid MF
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591627
[TBL] [Abstract][Full Text] [Related]
17. New strategies to manage complicated pleural effusions.
Safiyeh M; Huang D
Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
19. tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.
Maiga A; Pinkerman R; Deppen SA; Scruggs J; Mcguire P; Tarpley JL; Grogan EL
Am Surg; 2017 Dec; 83(12):1458-1459. PubMed ID: 29336772
[No Abstract] [Full Text] [Related]
20. Alteplase in the treatment of complicated parapneumonic effusion: a case report.
Bishop NB; Pon S; Ushay HM; Greenwald BM
Pediatrics; 2003 Feb; 111(2):E188-90. PubMed ID: 12563094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
